These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7339639)
21. Plasma level and effect of low-dose haloperidol in acute psychosis. Bleeker JA; Dingemans PM; Frohn-de Winter ML; van de Slooten EP Psychopharmacol Bull; 1984; 20(2):317-9. PubMed ID: 6728996 [No Abstract] [Full Text] [Related]
22. Computerized EEG study on drug-induced extrapyramidalism in schizophrenic patients. Saito M; Kita S; Kagono Y; Suitsu N; Honda Y Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():524-37. PubMed ID: 6962040 [No Abstract] [Full Text] [Related]
23. Comparison of haloperidol plasma concentrations between twice-a-day and once-a-day dosing in Chinese schizophrenic patients. Lin SK; Chen CH; Chang WH J Formos Med Assoc; 1993 Sep; 92(9):832-4. PubMed ID: 7904867 [TBL] [Abstract][Full Text] [Related]
33. Influence of route of administration on haloperidol plasma levels in psychotic patients. Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678 [TBL] [Abstract][Full Text] [Related]
34. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects]. Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089 [TBL] [Abstract][Full Text] [Related]
35. Electroencephalographic changes and other indices of neurotoxicity with haloperidol-lithium therapy. Saran A; Addy O; Foliart RH; Schubert DS; Halaris A Neuropsychobiology; 1989; 20(3):152-7. PubMed ID: 2569693 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic window for plasma haloperidol in acute schizophrenic psychosis. Extein I; Pottash AL; Gold MS Lancet; 1983 May; 1(8332):1048-9. PubMed ID: 6133089 [No Abstract] [Full Text] [Related]
37. Haloperidol concentrations in saliva and serum: determination by the radioimmunoassay method. Yamazumi S; Miura S Int Pharmacopsychiatry; 1981; 16(3):174-83. PubMed ID: 7198629 [TBL] [Abstract][Full Text] [Related]
38. Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophrenia. Leroux JM; Elia E; Jacquet M; Pommery J; Levron JC; Bouhours P; Erb F; Sechter D Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):347-53. PubMed ID: 8208983 [TBL] [Abstract][Full Text] [Related]
39. Serum haloperidol and neuroleptic receptor levels in chronic psychosis. Cannon DJ; McMillan DE; Newton JE; Fody EP; Metzer WS; Claybrook M; Couch L; Paige SR Ann Clin Lab Sci; 1988; 18(5):378-83. PubMed ID: 3178137 [TBL] [Abstract][Full Text] [Related]
40. Distribution and metabolism of neuroleptic drugs. I. Pharmacokinetics of haloperidol. Lewi PJ; Heykants JJ; Allewijn FT; Dony JG; Janssen PA Arzneimittelforschung; 1970 Jul; 20(7):943-8. PubMed ID: 5536066 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]